COVID-19

Covid-19 Update: Epidemiology, Virology, Drugs & Vaccines, and UCSF’s Experience in Navajo Nation

In this UCSF Medical Grand Rounds presentation (May 7, 2020), UCSF experts provide an update on the epidemiology and virology for COVID-19, prospects for drugs and vaccines, and the role of biopharmaceutical companies. We also hear a brief report from a UCSF physician who is part of a volunteer group of 21 faculty and nurses working in the Navajo Nation. The session is hosted by UCSF Department of Medicine chair Bob Wachter.

Program
Bob Wachter: Introduction
00:02:16 – Sriram Shamasunder, Associate Professor of Medicine, UCSF Division of Hospital Medicine; Director of the HEAL Initiative – Report from the Navajo Nation
00:13:22 – George Rutherford, Professor, Dept. of Epidemiology & Biostatistics; Director of the Prevention and Public Health Group – Epidemiology and the Next Stage
00:25:20 – Q&A
00:32:32 – Joel Ernst, Professor of Medicine and Chief of UCSF Division of Experimental Medicine – Viral Immunity and Vaccines
00:45:45 –Melanie Ott, Senior Investigator, Gladstone Institute of Virology and Immunology and Professor, Dept. of Medicine – Virology of SARS-CoV-2
00:58:55 – Nevan Krogan, Professor, Dept. of Cellular and Molecular Pharmacology; Director of Quantitative Biosciences Institute – SARS-CoV-2 and Drug Discovery
01:13:30 – Panel Discussion including Joel Ernst, Melanie Ott, Nevan Krogan and:
• Donald Ganem, Professor Emeritus of Medicine, Division of Infectious Diseases; Head of Infectious Disease Research at Novartis, 2011-18 – SARS-CoV-2 and the Role of Biopharmaceutical Companies
01:38:23 – Bob Wachter: Closing

See previous Covid-19 Medical Grand Rounds:
• April 30: Update on Covid-19: Clinical & Neurological Manifestations, Contact Tracing, and UCSF’s Experience in NYC

• April 23: Update on Covid-19: The Next Stage of the Pandemic, Virology & Diagnostics
• April 16: Update on Covid-19: Epidemiology, Treatments, and Health Disparities

• April 9: Update on Covid-19, at UCSF and Around the Country

• April 2: Epidemiology, Science, Clinical Aspects, and Therapy for Covid-19, Part 2

• March 26: Impact on Covid-19 on Medical Education

• March 26: UCSF Researchers Tackling Covid-19

• March 19: Epidemiology, Science, Clinical Aspects, and Therapy for Covid-19, Part 1